Register information Patent

DE file number : 602 47 108.7 (Status: not pending/lapsed, Query started: May 28, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTNot pending/lapsed
21DE file number DAKZ602 47 108.7
96EP file numberEAKZ09 01 5376.8
97EP publication numberEPN2174945
54Designation/titleTIGegensinn-Modulierung der Apolipoprotein B Expression
51IPC main classICM
(ICMV)		 C07H 21/00 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C07H 21/02 (2006.01), C07H 21/04 (2006.01)
22DE application dateDATJul 30, 2002
96EP application dateEATJul 30, 2002
43Date of first publicationOTApr 14, 2010
Date of publication of grantPETApr 8, 2015
71/73Applicant/ownerINHKastle Therapeutics, LLC (n.d.Ges.d.Staates Delaware), Chicago, Ill., US
72InventorINCrooke, Rosanne M., CarlsbadCA 92009, US; Graham, Mark J., San ClementeCA 92672, US
74RepresentativeVTRMüller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
Address for service Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
135985
Apr 30, 2002
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
147196
May 15, 2002
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
920033
Aug 1, 2001
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002174945
Searchable text: EP000002174945
Original document: EP000002174945B1
Searchable text: EP000002174945B1
43Date of first publicationEVTApr 14, 2010
Date of the first transfer into DPMAregisterEREGTMay 27, 2011
Date of the (most recent) update in DPMAregisterREGTJan 5, 2025
(Show all update days)(Hide all update days)
  • Jan 5, 2025
    • Procedures: New representative details, New representative details, 13.09.2016: deleted
  • Aug 13, 2019; Apr 25, 2019; Mar 20, 2019; Aug 11, 2017; Aug 9, 2017; Oct 15, 2016; Sep 14, 2016; Apr 21, 2016; Mar 17, 2016; Aug 11, 2015; Aug 4, 2015; May 21, 2015; Apr 14, 2015; Apr 9, 2015; Nov 27, 2014; Feb 14, 2013
    • Historical data not available for this/these date(s)
  • May 27, 2011
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Apr 14, 2010  Details anzeigen
2 Procedure relating to EP application EPO publication of search report Apr 14, 2010  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA May 27, 2010 May 27, 2010 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Apr 8, 2015  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant May 21, 2015 May 21, 2015 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Jan 11, 2016 Apr 21, 2016 Details anzeigen
7 New applicant/owner details New applicant/owner details Sep 13, 2016 Oct 20, 2016 Details anzeigen
8 New applicant/owner details New applicant/owner details Sep 13, 2016 Oct 20, 2016 Details anzeigen
9 Administrative procedure Application is deemed to be withdrawn due to non-payment of annual fee/ IP right has lapsed due to non-payment of annual fee Feb 1, 2019 Apr 25, 2019 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTApr 14, 2010
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of search report
Date of legal/procedural statusVSTTApr 14, 2010
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 27, 2010
Issue numberHN21
YearPJ2010
Publication dateVTMay 27, 2010
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTApr 8, 2015
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTMay 21, 2015
Issue numberHN21
YearPJ2015
Publication dateVTMay 21, 2015
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTJan 11, 2016
Issue numberHN16
YearPJ2016
Publication dateVTApr 21, 2016
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTSep 13, 2016
Issue numberHN42
YearPJ2016
Publication dateVTOct 20, 2016
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHKastle Therapeutics, LLC (n.d.Ges.d.Staates Delaware), Chicago, Ill., US
71/73Previous applicant/ownerINHFIonis Pharmaceuticals, Inc. (n.d.Ges.d.Staates Delaware), Carlsbad, Calif., US
View procedures New applicant/owner details (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTSep 13, 2016
Issue numberHN42
YearPJ2016
Publication dateVTOct 20, 2016
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHIonis Pharmaceuticals, Inc. (n.d.Ges.d.Staates Delaware), Carlsbad, Calif., US
71/73Previous applicant/ownerINHFGenzyme Corp., Cambridge, Mass., US
View procedures Administrative procedure (No.: 9)
INIDCriterionFieldContent Close details
Type of procedureVARTAdministrative procedure
Legal/procedural statusVSTApplication is deemed to be withdrawn due to non-payment of annual fee/ IP right has lapsed due to non-payment of annual fee
Date of legal/procedural statusVSTTFeb 1, 2019
Issue numberHN17
YearPJ2019
Publication dateVTApr 25, 2019
Type of publicationPARTBibliographic data
PartHTPart 3